Xenon Pharmaceuticals Inc... (XENE)

XENE trades at $39.61, 13.2% above the near-term max pain of $35 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($7-$37.5), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for XENE shows an upward trend from 7 to 37.5, suggesting bullish positioning in longer-dated options. The 120% spread signals divergent expectations across timeframes. Most levels below 39.61 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.